Systemic and oral clearances of alfentanil are in vivo probes for hepatic and first-pass CYP3A. Both alfentanil single point plasma concentrations and miosis are surrogates for area under the concentration-time curve (AUC), clearance, and are minimal and non-invasive CYP3A probes. This investigation determined alfentanil sensitivity for detecting graded CYP3A induction, and compared it with that of midazolam Twelve volunteers (sequential crossover) received 0, 5, 10, 25 or 75 mg oral rifampin for 5d. Midazolam and alfentanil were given intravenously and orally on sequential days. Dark-adapted pupil diameters were measured with blood sampling. Graded rifampin decreased plasma midazolam AUCs to 83, 76, 62 and 59% (intravenous) and 78, 66, 39, and 24% (oral) of control. Hepatic and first-pass CYP3A induction were detected comparably by plasma midazolam and alfentanil AUCs. Single alfentanil concentrations detected all CYP3A induction, while midazolam was less sensitive. Alfentanil miosis detected induction of first-pass but not hepatic CYP3A.